Qube Research & Technologies (QRT)
MET icon

Qube Research & Technologies (QRT)’s MetLife MET Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$127K Sell
1,800
-13,700
-88% -$1.03M ﹤0.01% 3032
2025
Q4 		$1.22M Sell
15,500
-200
-1% -$15.8K ﹤0.01% 2469
2025
Q3 		$1.29M Buy
15,700
+100
+0.6% +$7.87K ﹤0.01% 2413
2025
Q2 		$1.25M Buy
15,600
+10,600
+212% +$818K ﹤0.01% 2381
2025
Q1 		$401K Buy
5,000
+3,800
+317% +$316K ﹤0.01% 2627
2024
Q4 		$98.3K Buy
+1,200
New +$99.9K ﹤0.01% 2997
2024
Q3 		– Sell
-100
Closed -$7.02K – 3799
2024
Q2 		$7.02K Buy
+100
New +$7.14K ﹤0.01% 2992
2023
Q4 		– Sell
-13,400
Closed -$843K – 4578
2023
Q3 		$843K Buy
+13,400
New +$835K ﹤0.01% 1811

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MET Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its MetLife (MET) stake by 25% in Q1 2026, buying an estimated $20.5M and bringing the position to 1,374,853 shares worth $97.2M. The position accounts for 0.11% of the portfolio, ranked #224.

Qube Research & Technologies (QRT) first reported a position in MET in Q1 2018 and has held it in 20 quarters since. The position peaked at $126M in Q4 2023. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Qube Research & Technologies (QRT) held 1,374,853 shares of MetLife worth $97.2M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 273,738 MetLife shares in Q1 2026, an estimated $20.5M.
  • MetLife made up 0.11% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #224 holding.
  • Qube Research & Technologies (QRT) first reported a position in MetLife in Q1 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s MetLife position peaked at $126M in Q4 2023.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.